Skip to main content
SpringerLink
Log in

Psychotropic Medication in Pregnancy: Focus on Child Outcomes

  • Chapter
  • First Online:
Pediatric Neurotoxicology

Part of the book series: Specialty Topics in Pediatric Neuropsychology ((STPN))

  • 704 Accesses

Abstract

Mental illness is one of the leading complications of childbirth and a leading indirect cause of maternal mortality in both the UK and Australia (Austin et al., Med J Aust 186:364–367, 2007; Oates, Br J Psychiatry 183:279–281, 2003). As identification of mental illness in pregnancy grows, attention naturally turns to a search for effective treatment, and steadily more and more this involves psychotropic medication. Both antidepressants and antipsychotics are rising in their use in adults as their role in treatment of mental disorders grows. This is probably driven in part by being simple and cost effective interventions in the developed world. The interaction between mental illness and pregnancy is complex. Many illnesses, such as bipolar affective disorder, may be exacerbated or precipitated by pregnancy. Relapses during this time pose a significant risk to mother and infant, with psychiatric-related deaths recognised as the leading cause of maternal death in developed countries (Austin et al., Med J Aust 186:364–367, 2007). Maternal mental illness is also associated with a range of pregnancy-related complications and adverse child outcomes. The effect of this evidence as it reaches the broader clinical community will be to prefer more assertive mental health care. Therefore, treatment with these medications during pregnancy is increasing as clinicians seek to ameliorate these risks. This chapter discusses the research into medications commonly used to treat psychiatric illness, namely antidepressants, antipsychotics and mood stabilisers. Although anticonvulsant medications are frequently used as mood stabilisers, they are addressed elsewhere in this publication and are not covered here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Altshuler, L., Cohen, L., Martin, S., Burt, V.K., Gitlin, M., Mintz, J. (1996). Pharmacological management of psychiatric illness during pregnancy: Dilemmas and guidelines. American Journal of Psychiatry, 153, 592–596.

    Google Scholar 

  • Anderson, B. M., Schnetz-Boutaud, N. C., Bartlett, J., Wotawa, A. M., Wright, H. H., Abramson R.K., … Haines J. (2009). Examination of association of genes in the serotonin system to autism. Neurogenetics, 10(3), 209–216.

    Google Scholar 

  • Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., … Platt, R. (2008). Use of antidepressant medications during pregnancy: A multisite study. American Journal of Obstetrics and Gynecology, 198, 194–195.

    Google Scholar 

  • Austin, M. P., Karatas, J. C., Mishra, P., Christl, B., Kennedy, D., & Oei, J. (2013). Infant neurodevelopment following in utero exposure to antidepressant medication. Acta Paediatrica, 102, 1054–1059.

    PubMed  Google Scholar 

  • Bakker, M. K., Kölling, P., van den Berg, P. B., de Walle, H. E. K., & de Jong van den Berg, L. T. (2008). Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British Journal of Clinical Pharmacology, 65(4), 600–606.

    Article  PubMed  Google Scholar 

  • Battle, C. L., & Salisbury, A. L. (2010). Treatment of antenatal depression. Journal of Midwifery and Women’s Health, 55, 479.

    Article  PubMed  Google Scholar 

  • Bergink, V., Bouvy, P. F., Vervoort, J. S. P., Koorengevel, K. M., Steegers, E. A. P., & Kushner, S. A. (2012). Prevention of postpartum psychosis and mania in women at high risk. American Journal of Psychiatry, 169(6), 609–615.

    Article  PubMed  Google Scholar 

  • Casper, R. C., Fleisher, B. E., Lee-Ancajas, J. C., Gilles, A., Gaylor, E., DeBattista, A., Hoymne, H. E. (2003). Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. Journal of Pediatrics, 142, 402–408.

    Google Scholar 

  • Casper, R. C., Gilles, A. A., Fleisher, B. E., Baran, J., Enns, G., & Lazzeroni, L. C. (2011). Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: Effects on neonatal adaptation and psychomotor development. Psychopharmacology, 217, 211–219.

    Article  PubMed  Google Scholar 

  • Chandana, S. R., Behen, M. E., Juhász, C., Muzik, O., Rothermel, R. D., Mangner, T. J., Chakraborty, P. K., Chugani, H. T., Chugani, D. C. (2005). Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. International Journal of Developmental Neuroscience, 23(2–3), 171–182.

    Google Scholar 

  • Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45(3), 287–295.

    Google Scholar 

  • Clements, C. C., Castro, V. M., Blumenthal, S. R., Rosenfield, H. R., Murphy, S. N., Fava, M., Erb, J. L., Churchill, S. E., Kaimal, A. J., Doyle, A. E., Robinson, E. B., Smoller, J. W., Kohane, I. S., Perlis, R. H. (2014). Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Molecular Psychiatry, 20, 727–734.

    Google Scholar 

  • Cohen, L. S., Altshuler, L. L., Harlow, B. L., Nonacs, R., Newport, D. J., Viguera, A. C., Suri R., Burt, V. K., Hendrick, V., Reminick, A. M., Loughead, A., Vitonis, A. F., Stowe, Z. N. (2006). Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA, 295, 499–507.

    Google Scholar 

  • Cohen, L. S., Friedman, J. M., & Jeffereson, J. W. (1994). A re-evaluation of risk of in-utero exposure to lithium. JAMA, 271, 146–150.

    Article  PubMed  Google Scholar 

  • Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology, 196, 544–545.

    PubMed  Google Scholar 

  • Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Hendrick, V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68(11), 1104–1112.

    Article  PubMed  Google Scholar 

  • Devlin, B., Cook, E. H. Jr, Coon, H., Dawson, G., Grigorenko, E. L., … C.P.E.A. Genetics Network (2005). Autism and the serotonin transporter: The long and short of it. Molecular Psychiatry, 10(12), 1110–1116.

    Google Scholar 

  • Duran, A., Ugur, M.M., Turan, S., Emuk, M. (2008). Clozapine use in two women with schizophrenia during pregnancy. Journal of Psychopharmacology, 22, 111–113.

    Google Scholar 

  • Egen-Lappe, V., & Hasford, J. (2004). Drug prescription in pregnancy: Analysis of a large statutory sickness fund population. European Journal of Clinical Pharmacology, 60, 659–666.

    Article  PubMed  Google Scholar 

  • Epstein, R. A., Bobo, W. V., Shelton, R. C., Arbogast, P. G., Morrow, J. A., Wang, W., … Cooper, W. O. (2013). Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiology and Drug Safety, 22(7), 794–801.

    Google Scholar 

  • Fish, B. (1977). Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect. Archives of General Psychiatry, 34(11), 1297–313.

    Google Scholar 

  • Galbally, M., Lewis, A. J., Lum, J., & Buist, A. (2009). Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: Prospective controlled study. Australian and New Zealand Journal of Psychiatry, 43, 846–854.

    Article  PubMed  Google Scholar 

  • Galbally, M., Lewis, A. J., & Buist, A. (2011). Developmental outcomes of children exposed to antidepressants in pregnancy. Australian and New Zealand Journal of Psychiatry, 45, 393–399.

    Article  PubMed  Google Scholar 

  • Galbally, M., Lewis, A., & Buist, A. (2015). Child developmental outcomes in preschool children following antidepressant exposure in pregnancy. Australian and New Zealand Journal of Psychiatry, 49(7), 642–650.

    Google Scholar 

  • Gaynes, B.N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., … Miller, W.C. (2005). Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evidence Report/Technology Assessment, 119, 1–8.

    Google Scholar 

  • Gentile, S. (2010). Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bulletin, 36, 518–544.

    Google Scholar 

  • Gupta, N., Grover, S. (2004). Safety of clozapine in 2 successive pregnancies. Canadian Journal of Psychiatry, 49, 863.

    Google Scholar 

  • Hanley, G. E., Brain, U., & Oberlander, T. F. (2013). Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Human Development, 89(8), 519–524.

    Article  PubMed  Google Scholar 

  • Harrington, R. A., Lee, L.-C., Crum, R. M., Zimmerman, A. W., & Hertz-Picciotto, I. (2014). Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics, 133(5), 1241–1248.

    Article  Google Scholar 

  • Hendrick, V., Smith, L. M., Suri, R., Hwang, S., Haynes, D., & Altshuler, L. (2003). Birth outcomes after prenatal exposure to antidepressant medication. American Journal of Obstetrics and Gynecology, 188, 812–815.

    Article  PubMed  Google Scholar 

  • Hviid, A., Melbye, M., & Pasternak, B. (2014). Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. New England Journal of Medicine, 369, 2406–2415.

    Article  Google Scholar 

  • Jacobsen, S.J., Jones, K., Johnson, K., Ceolin, L., Kaur, P., Sahn, D., … Santelli, R. (1992). Prospective multi-centre study of pregnancy outcome after lithium exposure during first trimester. Lancet, 339, 530–533.

    Google Scholar 

  • Johnson, K. C., LaPrairie, J. L., Brennan, P. A., Stowe, Z. N., & Newport, J. (2012). Prenatal antipsychotic exposure and neuromotor performance during infancty. Archives of General Psychiatry, 69(8), 787–794.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kieler, H., Artama, M., Engeland, A., Ericsson, O., Furu, K., Gissler, M.,… Haglund, B. (2012) Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. British Medical Journal 344, d8012.

    Google Scholar 

  • Klinger, G., Frankenthal, D., Merlob, P., Diamond, G., Sirota, L., Levinson-Castiel, R., … Inbar, D. (2011). Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Journal of Perinatology, 31, 615–620.

    Google Scholar 

  • Kolevzon, A., Mathewson, K. A., & Hollander, E. (2006). Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability. Journal of Clinical Psychiatry, 67(3), 407–414.

    Article  PubMed  Google Scholar 

  • Kozma, C. (2005). Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: Another clinical report and a review of the literature. American Journal of Medical Genetics, 132, 441–444.

    Article  Google Scholar 

  • Kris, E. B. (1965). Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Current Therapeutic Research, 7, 785–789.

    PubMed  Google Scholar 

  • Larsson, H. J., Eaton, W. W., Madsen, K. M., Vestergaard, M., Olesen, A. V., Agerbo, E., … Mortensen, P. B. (2004). Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. American Journal of Epidemiology, 161(10), 916–925.

    Google Scholar 

  • Laugesen, K., Olsen, M. S., Telen Andersen, A. B., Froslev, T., & Sorensen, H. T. (2013). In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: A nationwide Danish cohort study. BMJ Open, 2, 3(9).

    Google Scholar 

  • Lesesne, C. A., Visser, S. N., & White, C. P. (2003). Attention-deficit/hyperactivity disorder in school-aged children: Association with maternal mental health and use of health care resources. Pediatrics, 111(1), 1232–1237.

    PubMed  Google Scholar 

  • Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., & Klinger, G. (2006). Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Archives of Pediatric and Adolescent Medicine, 160, 173–176.

    Article  Google Scholar 

  • Lin, H., Chen, I., Chen, Y., Lee, H., Wu, F. (2010). Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Research, 116, 55–60.

    Google Scholar 

  • Man, K. K., Ton, H. H., Wong, L. Y., Chan, E. W., Simonoff, E., & Wong, I. C. (2015). Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies. Neuroscience and Biobehaviour Review, 49C, 82–89.

    Article  Google Scholar 

  • Mattson, S., Eastvold, A., Jones, K., Harris, J., & Chambers, C. (1999). Neurobehavioral follow-up of children prenatally exposed to fluoxetine. Teratology, 59, 376.

    Google Scholar 

  • McKenna, K., Koren, G., Tetelbaum, M., Wilton, L., Shakir, S., Diav-Citrin, O., … Einarson, A. (2005). Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study. Journal of Clinical Psychiatry, 66, 444–449.

    Google Scholar 

  • Mendhekar, D.N. (2007). Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation. Journal of Neuropsychiatry and Clinical Neuroscience, 19, 196–197.

    Google Scholar 

  • Miller, L. J., & Finnerty, M. (1996). Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatric Services, 47, 502–506.

    Article  PubMed  Google Scholar 

  • Misri, S., Reebye, P., Kendrick, K., Carter, D., Ryan D., Grunau, R.E., & Oberlander, T. F. (2006). Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. American Journal of Psychiatry, 163, 1026–1032.

    Google Scholar 

  • Mortensen, J. T., Olsen, J., Larsen, H., Bendsen, J., Obel, C., & Sorensen, H. T. (2003). Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. European Journal of Epidemiology, 18, 769–771.

    Article  PubMed  Google Scholar 

  • Moses-Kolko, E. L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B., & Wisner, K. L. (2005). Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications. JAMA, 293, 2372–2383.

    Google Scholar 

  • Murphy, D. G. M., Daly, E., Schmitz, N., Toal, F., Murphy, K., Curran, S., … Travis, M. (2006). Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger’s syndrome: An in vivo SPECT study. American Journal of Psychiatry, 163(5), 934–936.

    Google Scholar 

  • Niemi, L.T., Suvisaari, J.M., Tuulio-Henriksson, A., Lonnqvist, J.K. (2003). Childhood developmental abnormalities in schizophrenia: evidence from high risk studies. Schizophrenia Research, 602, 239–258.

    Google Scholar 

  • Nora, J. J., Nora, A. H., & Toews, W. H. (1974). Lithium, Ebstein’s anomaly and other congenital heart defects. Lancet, 2, 594–595.

    Article  PubMed  Google Scholar 

  • Nulman, I., Koren, G., Rovet, J., Barrera, M., Pulver, A., Streiner, D., & Feldman, B. (2012). Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. American Journal of Psychiatry, 169, 1165–1174.

    Google Scholar 

  • Nulman, I., Rovet, J., Stewart, D.E., Wolpin, J., Gardner, H. A., Theis, J. G., … Koren, G. (1997). Neurodevelopment of children exposed in utero to antidepressant drugs. New England Journal of Medicine, 336, 258–262.

    Google Scholar 

  • Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., & Koren, G. (2002). Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study. American Journal of Psychiatry, 159, 1889–1895.

    Google Scholar 

  • Oberlander, T. F., Grunau, R. E., Fitzgerald, C., Papsdorf, M., Rurak, D., & Riggs, W. (2005). Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics, 115, 411–425.

    Article  PubMed  Google Scholar 

  • Oberlander, T. F., Grunau, R., Mayes, L., Riggs, W., Rurak, D., Papsdorf, M., & Misri, S., Weinberg, J. (2008). Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Human Development, 84, 689–697.

    Google Scholar 

  • Oberlander, T. F., Papsdorf, M., Brain, U. M., Misri, S., Ross, C., & Gruneau, R. E. (2010). Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Archives of Pediatric and Adolescent Medicine, 164, 444–451.

    Article  Google Scholar 

  • Oberlander, T. F., Reebye, P., Misri, S., Papsdorf, M., Kim, J., & Grunau, R. E. (2007). Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Archives of Pediatrica and Adolescent Medicine, 161, 22–29.

    Article  Google Scholar 

  • Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006). Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry, 63, 898–906.

    Article  PubMed  Google Scholar 

  • Pardo, C. A., & Eberhart, C. G. (2007). The neurobiology of autism. Brain Pathology, 17(4), 434–447.

    Article  PubMed  Google Scholar 

  • Pedersen, L. H., Henriksen, T. B., Bech, B. H., Licht, R. W., Kjaer, D., & Olsen, J. (2013). Prenatal antidepressant exposure and behavioral problems in early childhood—A cohort study. Acta Psychiatrica Scandinavia, 127, 126–135.

    Article  Google Scholar 

  • Pederson, L., Henriksen, T. B., & Olsen, J. (2010). Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics, 125, e600–e608.

    Article  Google Scholar 

  • Peng, M., Gao, K., Ding, Y., Ou, J., Calabrese, J., Wu, R., Zhao, J. (2013). Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology, 228, 577–584.

    Google Scholar 

  • Rai, D., Lee, B., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013). Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case-control study. British Medical Journal, 346, f2059.

    Article  PubMed  PubMed Central  Google Scholar 

  • Reebye, P. N., Morison, S. J., Panikkar, H., Misri, S., & Grunau, R. E. (2002). Affect expression in prenatally psychotropic exposed and nonexposed mother–infant dyads. Infant Mental Health Journal, 23, 403–416.

    Article  Google Scholar 

  • Reebye, P. N., Ng, T. W. C., Misri, S., & Stikarovska, I. (2012). Affect expression and self-regulation capacities of infants exposed in utero to psychotropics. Frontiers in Psychiatry, 3, 11.

    Article  PubMed  PubMed Central  Google Scholar 

  • Schou, M. (1976). What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatrica Scandinavia, 54, 193–197.

    Article  Google Scholar 

  • Simard, M., Gumbiner, B., Lee, A., Lewis, H., & Norman, D. (1989). Lithium carbonate intoxication. A case report and review of the literature. Archives of Internal Medicine, 149, 36–46.

    Article  PubMed  Google Scholar 

  • Sorensen, M. J., Gronborg, T. K., Christensen, J., Parner, E. T., Vestergaard, M., Schendel, D., & Pedersen, L. H. (2013) Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clinical Epidemiology, 5, 449–459.

    Google Scholar 

  • Stika, L., Elisova, K., Honzakova, L., Hrochova, H., Plechatova, H., Strnadova, J., … Vinar, O. (1990). Effects of drug administration in pregnancy on children’s school behaviour. Pharmaceutisch Weekblad, 12, 252–255.

    Google Scholar 

  • Thiels, C. (1987). Pharmacotherapy of psychiatric disorder in pregnancy and during breastfeeding: a review. Psychopharmacology, 20, 133–146.

    Google Scholar 

  • Toh, S., Li, Q., Cheetham, T. C., Cooper, W. O., Davis, R. L., Dublin, S., Hammad, T. A., … Andrade, S. E. (2013). Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001-2007: A population-based study of 585,615 deliveries. Archives of Women’s Mental Health, 16(2), 149–157.

    Google Scholar 

  • van der Lugt, N. M., van de Matt, J. S., van Kamp, I. L., Knoppert-van der Klein, E. A., Hovens, J. G., & Walther, F. J. (2012). Fetal, neonatal and developmental outcomes of lithium exposed pregnancies. Early Human Development, 88, 375–378.

    Article  PubMed  Google Scholar 

  • Ververs, T., Kaasenbrood, H., Visser, G., Schobben, F., De Jong-Van Den Berg, L., & Egberts, T. (2006). Prevalence and patterns of anti-depressant drug use during pregnancy. European Journal of Clinical Pharmacology, 62, 863–870.

    Article  PubMed  Google Scholar 

  • Viguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., & Baldessarini, R. J. (2000). Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. American Journal of Psychiatry, 157(2), 179–184.

    Article  PubMed  Google Scholar 

  • Wan, M.W., Abel, K.M., Green, J. (2008). The transmission of risk to children from mothers with schizophrenia: a developmental psychopathology model. Clinical Psychology Review, 28(4), 613–637.

    Google Scholar 

  • Warburton, W., Hertzman, C., & Oberlander, T. F. (2010). A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatrica Scandinavia, 121, 471–479.

    Article  Google Scholar 

  • Webb, R., Avel, K., Pickles, A., & Appleby, L. (2005). Mortality in offspring of parents with psychotic disorders: A critical review and meta-analysis. American Journal of Psychiatry, 162(6), 1045–1056.

    Article  PubMed  Google Scholar 

  • Weikum, W. M., Oberlander, T. F., Hensch, T. K., & Werker, J. F. (2012). Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Procedures of the National Academy of Sciences (USA), 109(2), 17221–17227.

    Article  Google Scholar 

  • Whitaker-Azmitia, P. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56(5), 479–485.

    Article  PubMed  Google Scholar 

  • Weikum, W.M., Brain, U., Chau, C.M.Y., Grunau, R.E., Boyce, W.T., Diamond, A., Oberlander, T.F. (2013). Prenatal serotonin reuptake inhibitor antidepressant exposure and serotonin transporter promoter geneotype (SLC6A4) influence executive functions at 6 years of age. Frontiers in Cellular Neuroscience, 7, 120–131.

    Google Scholar 

  • Williams, K., Wheeler, D. M., Silove, N., & Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Systematic Review, 8(8), CD004677.

    Google Scholar 

  • Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., Altshuler, L. (2004). Management of bipolar disorder during pregnancy and the postpartum period. American Journal of Psychiatry, 161(4), 608–620.

    Google Scholar 

  • Zeskind, P. S., & Stephens, L. E. (2004). Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics, 113, 368–375.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Perinatal Mental Health, Mercy Hospital for Women, Melbourne, VIC, Australia

    Josephine Power M.B.B.S., M.P.M., F.R.A.N.Z.C.P.

  2. General Hospital Mental Health, Austin Health, Melbourne, VIC, Australia

    Josephine Power M.B.B.S., M.P.M., F.R.A.N.Z.C.P.

  3. Foundation Chair in Perinatal Psychiatry, Murdoch University, University of Notre Dame and Fiona Stanley Hospital, Murdoch, WA, Australia

    Megan Galbally M.B.B.S., F.R.A.N.Z.C.P., Ph.D.

  4. School of Psychology, Deakin University, Waurn Ponds, VIC, Australia

    Andrew Lewis Ph.D.

Authors
  1. Josephine Power M.B.B.S., M.P.M., F.R.A.N.Z.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Megan Galbally M.B.B.S., F.R.A.N.Z.C.P., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew Lewis Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josephine Power M.B.B.S., M.P.M., F.R.A.N.Z.C.P. .

Editor information

Editors and Affiliations

  1. Department of Educational Psychology and Institute of Neuroscience, Texas A&M University, College Station, Texas, USA

    Cynthia A. Riccio

  2. Department of Educational Psychology, University of Texas at San Antonio, San Antonio, Texas, USA

    Jeremy R. Sullivan

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Power, J., Galbally, M., Lewis, A. (2016). Psychotropic Medication in Pregnancy: Focus on Child Outcomes. In: Riccio, C., Sullivan, J. (eds) Pediatric Neurotoxicology. Specialty Topics in Pediatric Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-32358-9_6

Download citation

Publish with us

Policies and ethics

Search

Navigation